首页> 外文期刊>Oncology letters >Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines
【24h】

Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines

机译:非典型趋化因子受体D6通过螯合趋化因子抑制人非小细胞肺癌的生长

获取原文
获取原文并翻译 | 示例
           

摘要

Chemokines and their receptors have been shown to play a vital role in lung cancer progression. D6 is an atypical chemokine receptor which is able to internalize and degrade chemokines. To investigate the potential role of D6 in lung cancer, we established D6-overexpressing A549 lung cancer cell. lines by the transfection of human D6 cDNA. Results showed that D6 inhibited the proliferation of cancer cells in vitro and tumorigenesis in vivo. We also determined chemokine levels in the supernatant and showed that a number of chemokines (CCL2/4/5) had significantly decreased protein levels in D6-overexpressing cells compared with the controls, whereas no significant changes in mRNA expression levels of these chemokines were detected. The cell cycle distribution and expression of certain growth factors and their receptors did not change in the D6-overexpressing cell compared with parental cells. Thus, our results suggest that D6 is a negative regulator of growth in lung cancer, mainly by the sequestration of specific chemokines.
机译:趋化因子及其受体已被证明在肺癌的进展中起着至关重要的作用。 D6是一种非典型趋化因子受体,能够内化和降解趋化因子。为了研究D6在肺癌中的潜在作用,我们建立了D6过表达的A549肺癌细胞。通过人D6 cDNA的转染来鉴定品系。结果表明,D6在体外抑制癌细胞的增殖和体内肿瘤发生。我们还测定了上清液中的趋化因子水平,并显示与对照相比,许多趋化因子(CCL2 / 4/5)在过表达D6的细胞中蛋白质水平显着降低,而未检测到这些趋化因子的mRNA表达水平有明显变化。 。与亲代细胞相比,D6过表达细胞中某些生长因子及其受体的细胞周期分布和表达没有变化。因此,我们的结果表明,D6是肺癌生长的负调节剂,主要是通过隔离特定的趋化因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号